Assessing clinical and functional outcomes in a gene-environment interaction study in first episode of psychosis (PEPs);Criterios de valoración clínicos y de funcionamiento en un estudio de interacción gen-ambiente en primeros episodios psicóticos (PEPs)

Revista de Psiquiatria y Salud Mental

Volumn 6, Issue 1, 2013, Pages 4-16

  Bernardo, Miquel ^a,b   Bioque, Miquel ^a,b   Parellada, Mara ^a,c   Saiz Ruiz, Jerónimo ^a,d   Cuesta, Manuel J ^a,e   Llerena, Adrián ^a,f   Sanjuán, Julio ^a,g   Castro Fornieles, Josefina ^a,b   Arango, Celso ^a,c   Cabrera, Bibiana ^b  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d UNIVERSITY OF ALCALÁ   (Spain)

^e Universidad Pública de Navarra   (Spain)

^f UNIVERSITY OF EXTREMADURA   (Spain)

^g UNIVERSITY OF VALENCIA   (Spain)

Author keywords

First episode of psychosis; Functional assessment; Outcome measures; Psychopathology assessment; Schizophrenia

Indexed keywords

ADVERSE OUTCOME; ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; GENETIC POLYMORPHISM; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PSYCHOSIS; SPAIN; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; CHILD; CLINICAL PROTOCOLS; DISEASE PROGRESSION; FEMALE; GENE-ENVIRONMENT INTERACTION; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; PSYCHOLOGICAL TESTS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SPAIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84873300364     PISSN: 18889891     EISSN: 19894600     Source Type: Journal    
DOI: 10.1016/j.rpsm.2012.11.001     Document Type: Article

References (117)

1. J. Perala, J. Suvisaari, S.I. Saarni, K. Kuoppasalmi, E. Isometsa, and S. Pirkola Lifetime prevalence of psychotic and bipolar i disorders in a general population Arch Gen Psychiatry 64 2007 19 28
2. C.T. Gordon, J.A. Frazier, K. McKenna, J. Giedd, A. Zametkin, and T. Zahn Childhood-onset schizophrenia: An NIMH study in progress Schizophr Bull 20 1994 697 712
3. J. Edwards, D. Maude, P.D. McGorry, S.M. Harrigan, and J.T. Cocks Prolonged recovery in first-episode psychosis Br J Psychiatry Suppl 172 1998 107 116
4. D. Linszen, P. Dingemans, and M. Lenior Early intervention and a five year follow up in young adults with a short duration of untreated psychosis: Ethical implications Schizophr Res 1 2001 55 61
5. X. Goldberg, M. Fatjó-Vilas, M.J. Muñoz, S. Campanera, S. Miret, and M.J. Minano Increased familiarity of intellectual deficits in early-onset schizophrenia spectrum disorders World J Biol Psychiatry 2011
6. J. Olesen, A. Gustavsson, M. Svensson, H.U. Wittchen, and B. Jonsson The economic cost of brain disorders in Europe Eur J Neurol 19 2011 155 162
7. C.G. Huber, D. Naber, and M. Lambert Incomplete remission and treatment resistance in first-episode psychosis: Definition, prevalence and predictors Expert Opin Pharmacother 9 2008 2027 2038
8. M. Alvarez-Jimenez, A.G. Parker, S.E. Hetrick, P.D. McGorry, and J.F. Gleeson Preventing the second episode: A systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis Schizophr Bull 37 2009 619 630
9. J.A. Lieberman, T.S. Stroup, J.P. McEvoy, M.S. Swartz, R.A. Rosenheck, and D.O. Perkins Effectiveness of antipsychotic drugs in patients with chronic schizophrenia N Engl J Med 353 2005 1209 1223
10. J.P. McEvoy, J.A. Lieberman, D.O. Perkins, R.M. Hamer, H. Gu, and A. Lazarus Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: A randomized, double-blind 52-week comparison Am J Psychiatry 164 2007 1050 1060
11. R.S. Kahn, W.W. Fleischhacker, H. Boter, M. Davidson, Y. Vergouwe, and I.P. Keet Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: An open randomised clinical trial Lancet 371 2008 1085 1097
12. M. Bertelsen, P. Jeppesen, L. Petersen, A. Thorup, J. Ohlenschlaeger, and P. le Quach Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: The OPUS trial Arch Gen Psychiatry 65 2008 762 771
13. M. Bertani, A. Lasalvia, C. Bonetto, S. Tosato, D. Cristofalo, and S. Bissoli The influence of gender on clinical and social characteristics of patients at psychosis onset: A report from the Psychosis Incident Cohort Outcome Study (PICOS) Psychol Med 2011 1 12
14. C. Arango, M. Rapado-Castro, S. Reig, J. Castro-Fornieles, A. Gonzalez-Pinto, and S. Otero Progressive brain changes in children and adolescents with first-episode psychosis Arch Gen Psychiatry 69 2012 16 26
15. J. Castro-Fornieles, M. Parellada, C.A. Soutullo, I. Baeza, A. Gonzalez-Pinto, and M. Graell Antipsychotic treatment in child and adolescent first-episode psychosis: A longitudinal naturalistic approach J Child Adolesc Psychopharmacol 18 2008 327 336
16. V. Peralta, M.J. Cuesta, A. Martinez-Larrea, and J.F. Serrano Differentiating primary from secondary negative symptoms in schizophrenia: A study of neuroleptic-naive patients before and after treatment Am J Psychiatry 157 2000 1461 1466
17. P. McGorry Welcome to early intervention in Psychiatry Early Interv Psychiatry 1 2007 1 2
18. P. Fusar-Poli, and A.R. Yung Should attenuated psychosis syndrome be included in DSM-5? Lancet 379 2012 591 592
19. W. Carpenter It is time for a new paradigm for the study of psychoses Rev Psiquiatr Salud Ment 3 2010 1 3
20. M. Marshall, and J. Rathbone Early intervention for psychosis Schizophr Bull 37 2011 1111 1114
21. C. Arango Mental health research in Spain: A bit more than green shoots Rev Psiquiatr Salud Ment 5 2012 211 213
22. J. Van Os [Solutions for patients depend on whether we can bridge the divide between social and natural science research approaches in the area of mental health] Rev Psiquiatr Salud Ment 5 2012 135 138
23. J.L. Waddington, A.P. Corvin, G. Donohoe, C.M. O'Tuathaigh, K.J. Mitchell, and M. Gill Functional genomics and schizophrenia: Endophenotypes and mutant models Psychiatr Clin North Am 30 2007 365 399
24. P.J. Harrison, and M.J. Owen Genes for schizophrenia? Recent findings and their pathophysiological implications Lancet 361 2003 417 419
25. P.C. Sham, P. Jones, A. Russell, K. Gilvarry, P. Bebbington, and S. Lewis Age at onset, sex, and familial psychiatric morbidity in schizophrenia. Camberwell Collaborative Psychosis Study Br J Psychiatry 165 1994 466 473
26. A. Valiente, A. Lafuente, and M. Bernardo Systematic review of the Genomewide Association Studies (GWAS) in schizophrenia Rev Psiquiatr Salud Ment 4 2011 218 227
27. J. Van Os, and P. McGuffin Can the social environment cause schizophrenia? Br J Psychiatry 182 2003 291 292
28. J. Van Os, M. Hanssen, M. Bak, R.V. Bijl, and W. Vollebergh Do urbanicity and familial liability coparticipate in causing psychosis? Am J Psychiatry 160 2003 477 482
29. J. Van Os, and P. Delespaul Psychosis research at Maastricht University, The Netherlands Br J Psychiatry 183 2003 559 560
30. A.R. Sanders, J. Duan, D.F. Levinson, J. Shi, D. He, and C. Hou No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: Implications for psychiatric genetics Am J Psychiatry 165 2008 497 506
31. M.J. Owen, N. Craddock, and M.C. O'Donovan Schizophrenia: genes at last? Trends Genet 21 2005 518 525
32. M.J. Owen, N. Craddock, and M.C. O'Donovan Suggestion of roles for both common and rare risk variants in genome-wide studies of schizophrenia Arch Gen Psychiatry 67 2010 667 673
33. A.J. Allen, M.E. Griss, B.S. Folley, K.A. Hawkins, and G.D. Pearlson Endophenotypes in schizophrenia: a selective review Schizophr Res 109 2009 24 37
34. M. Bernardo, and M. Bioque Schizophrenia: From neurobiology to nosology of mental disorders Actas Esp Psiquiatr 38 Supl 3 2010 15 17
35. B. Kirkpatrick The concept of schizophrenia Rev Psiquiatr Salud Ment 2 2009 105 107
36. E. Fernandez-Egea, M. Bernardo, T. Donner, I. Conget, E. Parellada, and A. Justicia Metabolic profile of antipsychotic-naive individuals with non-affective psychosis Br J Psychiatry 194 2009 434 438
37. E. Fernandez-Egea, A. Bruna, C. Garcia-Rizo, M. Bernardo, and B. Kirkpatrick Stem cell signaling in newly diagnosed, antipsychotic-naive subjects with nonaffective psychosis Mol Psychiatry 14 2009 989 991
38. B. Kirkpatrick, E. Fernandez-Egea, C. Garcia-Rizo, and M. Bernardo Differences in glucose tolerance between deficit and nondeficit schizophrenia Schizophr Res 107 2009 122 127
39. R.I. Holt, C. Bushe, and L. Citrome Diabetes and schizophrenia 2005: are we any closer to understanding the link? J Psychopharmacol 19 6 Suppl 2005 56 65
40. M.C. Ryan, P. Collins, and J.H. Thakore Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia Am J Psychiatry 160 2003 284 289
41. M.C. Ryan, and J.H. Thakore Physical consequences of schizophrenia and its treatment: the metabolic syndrome Life Sci 71 2002 239 257
42. S. Saddichha, N. Manjunatha, S. Ameen, and S. Akhtar Diabetes and schizophrenia - effect of disease or drug? Results from a randomized, double-blind, controlled prospective study in first-episode schizophrenia Acta Psychiatr Scand 117 2008 342 347
43. E. Fernandez-Egea, M. Bernardo, C.M. Heaphy, J.K. Griffith, E. Parellada, and E. Esmatjes Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis Schizophr Bull 35 2009 437 442
44. M. De Hert, V. Schreurs, D. Vancampfort, and R. Van Winkel Metabolic syndrome in people with schizophrenia: A review World Psychiatry 8 2009 15 22
45. J.M. Meyer, and S.M. Stahl The metabolic syndrome and schizophrenia Acta Psychiatr Scand 119 2009 4 14
46. D.P. Osborn, C.A. Wright, G. Levy, M.B. King, R. Deo, and I. Nazareth Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: Systematic review and metaanalysis BMC Psychiatry 8 2008 84
47. K.M. Saari, S.M. Lindeman, K.M. Viilo, M.K. Isohanni, M.R. Jarvelin, and L.H. Lauren A 4-fold risk of metabolic syndrome in patients with schizophrenia: The Northern Finland 1966 Birth Cohort study J Clin Psychiatry 66 2005 559 563
48. J.H. Thakore, J.N. Mann, I. Vlahos, A. Martin, and R. Reznek Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia Int J Obes Relat Metab Disord 26 2002 137 141
49. A. Crescenti, P. Gasso, S. Mas, R. Abellana, R. Deulofeu, and E. Parellada Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with schizophrenia in a Spanish population Psychiatry Res 165 2009 175 180
50. M. Davidson Risk of cardiovascular disease and sudden death in schizophrenia J Clin Psychiatry 63 Suppl 9 2002 5 11
51. H. Koponen, A. Alaraisanen, K. Saari, O. Pelkonen, H. Huikuri, and M.J. Raatikainen Schizophrenia and sudden cardiac death: A review Nord J Psychiatry 62 2008 342 345
52. B. Kirkpatrick, E. Messias, P.D. Harvey, E. Fernandez-Egea, and C.R. Bowie Is schizophrenia a syndrome of accelerated aging? Schizophr Bull 34 2008 1024 1032
53. E.F. Torrey, J.J. Bartko, and R.H. Yolken Toxoplasma gondii and other risk factors for schizophrenia: An update Schizophr Bull 38 2012 642 647
54. R. Tandon, M.S. Keshavan, and H.A. Nasrallah Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology Schizophr Res 102 2008 1 18
55. M. Cannon, and M.C. Clarke Risk for schizophrenia - broadening the concepts, pushing back the boundaries Schizophr Res 79 2005 5 13
56. D. Collip, I. Myin-Germeys, and J. van Os Does the concept of "sensitization" provide a plausible mechanism for the putative link between the environment and schizophrenia? Schizophr Bull 34 2008 220 225
57. M. Rutter How the environment affects mental health Br J Psychiatry 186 2005 4 6
58. A. Caspi, T.E. Moffitt, M. Cannon, J. McClay, R. Murray, and H. Harrington Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction Biol Psychiatry 57 2005 1117 1127
59. T. Lataster, J. van Os, M. Drukker, C. Henquet, F. Feron, and N. Gunther Childhood victimisation and developmental expression of non-clinical delusional ideation and hallucinatory experiences: Victimisation and non-clinical psychotic experiences Soc Psychiatry Psychiatr Epidemiol 41 2006 423 428
60. American Psychiatric Association (Washington) DSM-IV: diagnostic and statistical manual of mental disorders 4th ed. 1994 American Psychiatric Association Washington, DC
61. J. Kaufman, B. Birmaher, D. Brent, U. Rao, C. Flynn, and P. Moreci Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): Initial reliability and validity data J Am Acad Child Adolesc Psychiatry 36 1997 980 988
62. M. First, R. Spitzer, M. Gibbon, and J. Williams Structured clinical interview for DSM-IV axis i disorders - Administration booklet 1994 American Psychiatric Press Inc Washington, DC
63. M. First, M. Gibbon, R. Spitzer, and J. Williams Structured clinical interview for DSM-IV axis ii personality disorders (SCID-II) 1997 American Psychiatry Publishing, Inc Washington, DC
64. M. First, R. Spitzer, M. Gibbon, and J. Williams Entrevista clínica estructurada para los trastornos del eje-i del DSM-IV 1999 Masson Barcelona
65. M. First, R. Spitzer, M. Gibbon, and J. Williams SCID-II: guía del usuario para la entrevista clínica estructurada para los trastornos de la personalidad 1999 Masson Barcelona
66. J. Ventura, R.P. Liberman, M.F. Green, A. Shaner, and J. Mintz Training and quality assurance with the structured clinical interview for DSM-IV (SCID-I/P) Psychiatry Res 79 1998 163 173
67. D.O. Perkins, J. Leserman, L.F. Jarskog, K. Graham, J. Kazmer, and J.A. Lieberman Characterizing and dating the onset of symptoms in psychotic illness: The Symptom Onset in Schizophrenia (SOS) inventory Schizophr Res 44 2000 1 10
68. J. Van Os, and S. Kapur Schizophrenia Lancet 374 2009 635 645
69. W. Guy ECDEU assessment manual for psychopharmacology - Revised 1976 Department of Health, Education and Welfare Rockville, MD
70. J. Endicott, R.L. Spitzer, J.L. Fleiss, and J. Cohen The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance Arch Gen Psychiatry 33 1976 766 771
71. D. Shaffer, M.S. Gould, J. Brasic, P. Ambrosini, P. Fisher, and H. Bird A children's global assessment scale (CGAS) Arch Gen Psychiatry 40 1983 1228 1231
72. J.L. Vazquez-Barquero, E. Vazquez Bourgon, S. Herrera Castanedo, J. Saiz, M. Uriarte, and F. Morales [Spanish version of the new World Health Organization Disability Assessment Schedule II (WHO-DAS-II): Initial phase of development and pilot study. Cantabria disability work group] Actas Esp Psiquiatr 28 2000 77 87
73. B. Reisberg Functional assessment staging (FAST) Psychopharmacol Bull 24 1988 653 659
74. J.M. Tanner Current advances in the study of physique. Photogrammetric anthropometry and an androgyny scale Lancet 1 1951 574 579
75. R.H. Moos, and B.S. Moos Family environment manual 2nd ed. 1986 Consulting Psychologists Press Palo Alto, CA
76. J. Davidson, and R. Smith Traumatic experiences in psychiatric outpatients J Trauma Stress 3 1990 459 475
77. S. Lewis, M.J. Owen, and R. Murray Obstetric complications and schizophrenia: methodology and mechanisms S. Schulz, H. Tamminga, Schizophrenia. A scientific focus 1989 Oxford University Press New York
78. F. Rice, A. Lewis, G. Harold, M. van den Bree, J. Boivin, and D.F. Hay Agreement between maternal report and antenatal records for a range of pre and peri-natal factors: The influence of maternal and child characteristics Early Hum Dev 83 2007 497 504
79. J.P. Wisdom, J.I. Manuel, and R.E. Drake Substance use disorder among people with first-episode psychosis: a systematic review of course and treatment Psychiatr Serv 62 2011 1007 1012
80. M.S. Swartz, J.W. Swanson, V.A. Hiday, R. Borum, H.R. Wagner, and B.J. Burns Violence and severe mental illness: the effects of substance abuse and nonadherence to medication Am J Psychiatry 155 1998 226 231
81. A. Kokkevi, and C. Hartgers EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence Eur Addict Res 1 1995 208 210
82. S.R. Kay, A. Fiszbein, and L.A. Opler The positive and negative syndrome scale (PANSS) for schizophrenia Schizophr Bull 13 1987 261 276
83. N.C. Andreasen, W.T. Carpenter Jr., J.M. Kane, R.A. Lasser, S.R. Marder, and D.R. Weinberger Remission in schizophrenia: proposed criteria and rationale for consensus Am J Psychiatry 162 2005 441 449
84. J. Van Os, T. Burns, R. Cavallaro, S. Leucht, J. Peuskens, and L. Helldin Standardized remission criteria in schizophrenia Acta Psychiatr Scand 113 2006 91 95
85. V. Peralta, and M. Cuesta Validación de la escala de los síndromes positivo y negativo (PANNS) en una muestra de esquizofrénicos españoles Actas Luso Esp Neurol Psiquiatr 22 1994 171 177
86. R.C. Young, J.T. Biggs, V.E. Ziegler, and D.A. Meyer A rating scale for mania: reliability, validity and sensitivity Br J Psychiatry 133 1978 429 435
87. F. Colom, E. Vieta, A. Martinez-Aran, M. Garcia-Garcia, M. Reinares, and C. Torrent [Spanish version of a scale for the assessment of mania: validity and reliability of the Young Mania Rating Scale] Med Clin (Barc) 119 2002 366 371
88. S.A. Montgomery, and M. Asberg A new depression scale designed to be sensitive to change Br J Psychiatry 134 1979 382 389
89. A. Lobo, L. Chamorro, A. Luque, R. Dal-Re, X. Badia, and E. Baro [Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton anxiety rating scales] Med Clin (Barc) 118 2002 493 499
90. S.J. Schmidt, D.R. Mueller, and V. Roder Social cognition as a mediator variable between neurocognition and functional outcome in schizophrenia: empirical review and new results by structural equation modeling Schizophr Bull 37 Suppl 2 2011 S41 S54
91. J. Sanjuan, L. Prieto, J.M. Olivares, S. Ros, A. Montejo, and F. Ferrer [GEOPTE Scale of social cognition for psychosis] Actas Esp Psiquiatr 31 2003 120 128
92. T.H. McGlashan Premorbid adjustment, onset types, and prognostic scaling: still informative? Schizophr Bull 34 2008 801 805
93. H.E. Cannon-Spoor, S.G. Potkin, and R.J. Wyatt Measurement of premorbid adjustment in chronic schizophrenia Schizophr Bull 8 1982 470 484
94. M.S. Swartz, D.O. Perkins, T.S. Stroup, J.P. McEvoy, J.M. Nieri, and D.C. Haak Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial Schizophr Bull 29 2003 33 43
95. O. Lingjaerde, U.G. Ahlfors, P. Bech, S.J. Dencker, and K. Elgen The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients Acta Psychiatr Scand Suppl 334 1987 1 100
96. G.M. Simpson, and J.W. Angus A rating scale for extrapyramidal side effects Acta Psychiatr Scand Suppl 212 1970 11 19
97. S. Reig, J. Sanchez-Gonzalez, C. Arango, J. Castro, A. Gonzalez-Pinto, and F. Ortuno Assessment of the increase in variability when combining volumetric data from different scanners Hum Brain Mapp 30 2009 355 368
98. M. Desco, J. Pascau, S. Reig, J.D. Gispert, A. Santos, and C. Benito Multimodality image quantification using Talairach grid Proceedings of SPIE Medical Imaging San Diego 2001
99. K.H. Nuechterlein, M.F. Green, R.S. Kern, L.E. Baade, D.M. Barch, and J.D. Cohen The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity Am J Psychiatry 165 Feb 2008 203 213
100. R.S. Kern, K.H. Nuechterlein, M.F. Green, L.E. Baade, W.S. Fenton, and J.M. Gold The MATRICS Consensus Cognitive Battery, part 2: Co-norming and standardization Am J Psychiatry 165 2008 214 220
101. D. Wechsler Wechsler intelligence scale for children-IV (WISC-IV) 4th ed 2003 Psychological Corporation San Antonio, TX
102. D. Wechsler Wechsler Adult Intelligence Scale-III (WAIS-III) 1997 The Psychological Corporation San Antonio, TX
103. C.K. Conners Continuous Performance Test II 2004 Multi-Health Systems Inc Toronto, Canada
104. C.J. Golden Stroop Color and Word Test. A manual for clinical and experimental uses 1978 Stoelting Co Wood Dale, Illinois
105. USA Army Army Individual Test Battery. Manual of directions and scoring 1944 War Department, Adjutant General's Office Washington, DC
106. R.K. Heaton, G.J. Chelune, J.L. Talley, G.G. Kay, and G. Curtiss Wisconsin Card Sorting Test Manual (revised and expanded) 1993 PAR Psychological Assessment Resources, Inc Odessa, Florida
107. E.A. Berg A simple objective technique for measuring flexibility in thinking J Gen Psychol 39 1948 15 22
108. R.M. Ruff, R.H. Light, S.B. Parker, and H.S. Levin Benton Controlled Oral Word Association Test: Reliability and updated norms Arch Clin Neuropsychol 11 1996 329 338
109. M.J. Benedet, and M.A. Alejandre Test de Aprendizaje Verbal España-Complutense (TAVEC) 1998 Tea Ediciones Madrid, España
110. M.J. Benedet, M.A. Alejandre, and A. Pamos Test de Aprendizaje Verbal España-Complutense Infantil (TAVECi) 1998 Tea Ediciones Madrid, España
111. J.D. Mayer, P. Salovey, and D.R. Caruso The Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT) 2002 Multi-Health Systmes Inc Toronto, Canada
112. S.R. Marder, W. Fenton, and K. Youens Schizophrenia, IX: Cognition in schizophrenia - the MATRICS initiative Am J Psychiatry 161 2004 25
113. R.C. Oldfield The assessment and analysis of handedness: The Edinburgh inventory Neuropsychologia 9 1971 97 113
114. Department of Health and the Medical Research Council. PsyGrid. Disponible en: http://www.psygrid.org [consultado 15 Jul 2012].
115. CIBERSAM, Centro de Investigación Biomédica En Red de Salud Mental. Disponible en: http://www.cibersam.es/cibersam/Plataformas [consultado 15 Jul 2012].
116. M. Davidson, S. Galderisi, M. Weiser, N. Werbeloff, W.W. Fleischhacker, and R.S. Keefe Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: A randomized, open-label clinical trial (EUFEST) Am J Psychiatry 166 2009 675 682
117. S. Galderisi, M. Davidson, R.S. Kahn, A. Mucci, H. Boter, and M.D. Gheorghe Correlates of cognitive impairment in first episode schizophrenia: The EUFEST study Schizophr Res 115 2009 104 114